BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS DEVICE-BASED TREATMENTS | GLOBAL MARKETS

132 Pages | 16 Exhibits | 2017 Analysis | Forecasts Through 2021 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for BPH and prostatitis treatment devices.

BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS DEVICE-BASED TREATMENTS MARKET HIGHLIGHTS

  • Symptomatic BPH and prostatitis affect over 100 million men worldwide, resulting in painful symptoms and lower quality of life.
  • Laser-based devices and urethral implants are expected to be the primary segments driving growth in the market.
  • The market for devices used to treat symptomatic BPH and prostatitis is anticipated to experience moderate growth during the forecast period (2016-21), increasing to an estimated $586.1m by 2021.
  • Pharmaceuticals continue to play a major role in the management and treatment of symptomatic patients, with device-based therapies being restricted to use in about 10-15% of all patients with symptomatic BPH and only the most severe cases of prostatitis.
  • The US market for device-based therapies currently accounts for approximately 40% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK). The strongest growth in device-based sales is expected to occur in the US.
Topics Covered Include:
  • An overview of device-based and pharmacological therapies for BPH and prostatitis.
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segement.
  • Discussion of key drivers and limiters to the BPH and prostatitis device-based treatments market.
  • Emerging therapies and their potential impact on the market for device-based treatments


TABLE OF CONTENTS:
EXECUTIVE SUMMARY
	
i. Methodology	

1. CLINICAL OVERVIEW OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATITIS
	
1.1 Benign Prostatic Hyperplasia	
	1.1.1 Symptoms	
	1.1.2 Diagnosis	
	1.1.3 Prevalence	
	1.1.4 Treatment	
1.2 Prostatitis	
	1.2.1 Symptoms	
	1.2.2 Diagnosis	
	1.2.3 Treatments	
1.3 Bibliography	

Exhibit 1-1: Treatment alternatives for patients with moderate to severe symptoms of BPH	
Exhibit 1-2: Summary of symptoms for types of prostatitis	

2. PRODUCTS FOR TREATING SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
	
2.1 Established Therapeutic Approaches	
	2.1.1 Drug therapy	
	2.1.2 Surgical treatment	
		2.1.2.1	Transurethral resection of the prostate	
			2.1.2.1.1 Selected TURP/BPVP products	
				2.1.2.1.1.1 KARL STORZ	
				2.1.2.1.1.2 Olympus	
				2.1.2.1.1.3 Richard Wolf	
	2.1.3 Less invasive alternatives to surgery	
		2.1.3.1	Transurethral incision of the prostate (TUIP)	
		2.1.3.2	Laser-based techniques	
			2.1.3.2.1 Holmium lasers	
			2.1.3.2.2 Greenlight lasers	
			2.1.3.2.3 Thulium lasers	
			2.1.3.2.4 Selected laser products for BPH	
				2.1.3.2.4.1 Boston Scientific	
				2.1.3.2.4.2 Jena Surgical	
				2.1.3.2.4.3 Lumenis	
				2.1.3.2.4.4 Richard Wolf	
		2.1.3.3	Other energy-based procedures	
			2.1.3.3.1 Transurethral microwave thermotherapy (TUMT)	
				2.1.3.3.1.1 Selected products for TUMT	
			2.1.3.3.2 Transurethral needle ablation (TUNA)	
				2.1.3.3.2.1 Selected products for TUNA	
			2.1.3.3.3 High-intensity focused ultrasound (HIFU) and water-induced thermotherapy	
		2.1.3.4	Prostatic implants	
			2.1.3.4.1 Stents	
			2.1.3.4.2 Prostatic urethral lift device	
		2.1.3.5	Prostatic artery embolization	
		2.1.3.6	Clinical development	
2.2 Market Forecasts	
	2.2.1 Global market for TURP equipment and related products for BPH	
	2.2.2 Global market for laser-based products for BPH	
	2.2.3 Global market for microwave and RF thermotherapy products for BPH	
	2.2.4 Global market for prostatic urethral lift implants for BPH	
	2.2.5 Global market for prostatic stents and PAE products for BPH	
	2.2.6 Market forecast: US	
		2.2.6.1 Drivers and limiters	
	2.2.7 Market forecast: EU	
	2.2.8 Market forecast: Japan	
	2.2.9 Market forecast: rest of the world	
2.3 Competitive Analysis	
	2.3.1 TURP and related equipment for vaporization and enucleation	
	2.3.2 Laser systems	
		2.3.2.1	TUMT/TUNA	
2.4 Bibliography	

Exhibit 2-1: Estimated number of men with symptomatic BPH, 2016-21 (thousands)	
Exhibit 2-2: Comparison of treatments for symptomatic BPH	
Exhibit 2-3: Global BPH therapy devices market forecast, by product segment, 2016-21 ($m)	
Exhibit 2-4: Global symptomatic BPH treatment devices, market forecast by country/region, 2016-21 ($m)	
Exhibit 2-5: US symptomatic BPH treatments, combined procedure volumes forecast, 2016-21	
Exhibit 2-6: US symptomatic BPH treatments, market forecast, 2016-21 ($m)	
Exhibit 2-7: 5EU symptomatic BPH treatments, combined procedure volumes forecast, 2016-21	
Exhibit 2-8: 5EU symptomatic BPH treatments, market forecast, 2016-21 ($m)	
Exhibit 2-9: Japan symptomatic BPH treatments, combined procedure volumes forecast, 2016-21	
Exhibit 2-10: Japan symptomatic BPH treatments, market forecast, 2016-21 ($m)	
Exhibit 2-11: RoW symptomatic BPH treatments, combined procedure volumes forecast, 2016-21	
Exhibit 2-12: RoW symptomatic BPH treatments, market forecast, 2016-21 ($m)	
Exhibit 2-13: TURP systems/electrodes global market, share by supplier, 2016	
Exhibit 2-14: BPH Laser systems global market, share by supplier, 2016	
Exhibit 2-15: TUMT/TUNA systems global market, share by supplier, 2016	

3. PRODUCTS FOR TREATING SYMPTOMATIC PROSTATITIS
	
3.1 Established Therapeutic Approaches	
	3.1.1 Drug therapy	
		3.1.1.1	Clinical development	
	3.1.2 Conservative non-pharmacologic therapy	
	3.1.3 Surgical/minimally invasive treatments	
		3.1.3.1	TURP	
		3.1.3.2	Minimally invasive thermotherapy	
			3.1.3.2.1 Microwave thermotherapy	
		3.1.3.3	External shock wave therapy	
3.2 Market Forecasts	
3.3 Bibliography	

Exhibit 3-1: National Institutes of Health prostatitis categories	

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Advin Urology
  2. Biolitec
  3. Boston Scientific
  4. CONMED
  5. Convergent Laser Technologies
  6. CoreTherm Medical
  7. Daiichi Sankyo
  8. Eisai
  9. Lilly/Eli Lilly and Company
  10. HistoSonics
  11. Insys Therapeutics
  12. Jena Surgical
  13. KARL STORZ
  14. Kissei Pharmaceutical
  15. LISA Laser USA
  16. Lumenis
  17. Medifocus
  18. Medtronic
  19. Merit Medical Systems
  20. NeoTract
  21. NxThera
  22. Nymox Pharmaceutical Corporation
  23. Olympus Medical/Olympus
  24. Pfizer
  25. Pnn Medical AS
  26. PROCEPT BioRobotics
  27. Richard Wolf
  28. Sophiris Bio
  29. Stryker
  30. Urologix
Contact Us

Need help finding medtech research? Let us help you!